BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9098263)

  • 1. Vitrectomy for complications of proliferative diabetic retinopathy. Functional outcomes.
    Smiddy WE; Feuer W; Irvine WD; Flynn HW; Blankenship GW
    Ophthalmology; 1995 Nov; 102(11):1688-95. PubMed ID: 9098263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual fields in patients who have undergone vitrectomy for complications of diabetic retinopathy. A prospective study.
    Barsam A; Laidlaw A
    BMC Ophthalmol; 2006 Jan; 6():5. PubMed ID: 16438726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification in patients with proliferative diabetic retinopathy.
    Lee DY; Jeong HS; Sohn HJ; Nam DH
    Retina; 2011 Oct; 31(9):1753-8. PubMed ID: 21555968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitrectomy in diabetic patients with a blind fellow eye.
    Bodanowitz S; Hesse L; Weinand F; Kroll P
    Acta Ophthalmol Scand; 1996 Feb; 74(1):84-8. PubMed ID: 8689491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results, prognostic factors and cataract surgery after diabetic vitrectomy: a 10-year follow-up study.
    Ostri C; Lux A; Lund-Andersen H; la Cour M
    Acta Ophthalmol; 2014 Sep; 92(6):571-6. PubMed ID: 24373516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreoretinal surgery outcomes. Impact on bilateral visual function.
    Scott IU; Smiddy WE; Merikansky A; Feuer W
    Ophthalmology; 1997 Jun; 104(6):1041-8. PubMed ID: 9186447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreoretinal surgery in diabetic patients on hemodialysis.
    Nawrocki J; Chrzanowski W; Koch D; Dziegielewski K
    Eur J Ophthalmol; 1997; 7(3):283-7. PubMed ID: 9352284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VISUALIZATION FROM INTRAOPERATIVE SWEPT-SOURCE MICROSCOPE-INTEGRATED OPTICAL COHERENCE TOMOGRAPHY IN VITRECTOMY FOR COMPLICATIONS OF PROLIFERATIVE DIABETIC RETINOPATHY.
    Gabr H; Chen X; Zevallos-Carrasco OM; Viehland C; Dandrige A; Sarin N; Mahmoud TH; Vajzovic L; Izatt JA; Toth CA
    Retina; 2018 Sep; 38 Suppl 1(Suppl 1):S110-S120. PubMed ID: 29324591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5.
    Arch Ophthalmol; 1990 Jul; 108(7):958-64. PubMed ID: 2196036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors, anatomical, and visual outcomes of injured eyes with proliferative vitreoretinopathy: eye injury vitrectomy study.
    Feng K; Hu Y; Wang C; Shen L; Pang X; Jiang Y; Nie H; Wang Z; Ma Z
    Retina; 2013 Sep; 33(8):1512-8. PubMed ID: 23538583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PREDICTING VISUAL OUTCOMES OF SECOND EYE VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
    Sulak M; Urbancic M; Petrovic MG
    Retina; 2018 Apr; 38(4):698-707. PubMed ID: 28333877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Different outcome among eyes with proliferative diabetic retinopathy indicated for vitrectomy].
    Muramatsu M; Yokoi M; Muramatsu A; Saito W; Furudate N; Ohno S
    Nippon Ganka Gakkai Zasshi; 2006 Dec; 110(12):950-60. PubMed ID: 17228758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early vitrectomy and endolaser photocoagulation in patients with type I diabetes with severe vitreous hemorrhage.
    Chaudhry NA; Lim ES; Saito Y; Mieler WF; Liggett PE; Filatov V
    Ophthalmology; 1995 Aug; 102(8):1164-9. PubMed ID: 9097742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitrectomy surgery in proliferative sickle retinopathy.
    Morgan CM; D'Amico DJ
    Am J Ophthalmol; 1987 Aug; 104(2):133-8. PubMed ID: 3618710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pars plana lensectomy, pars plana vitrectomy, and silicone oil tamponade as initial management of cataract and combined traction/rhegmatogenous retinal detachment involving the macula associated with severe proliferative diabetic retinopathy.
    Douglas MJ; Scott IU; Flynn HW
    Ophthalmic Surg Lasers Imaging; 2003; 34(4):270-8. PubMed ID: 12875454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual outcomes and complications after multiple vitrectomies for diabetic vitreous hemorrhage.
    Cooper B; Shah GK; Grand MG; Bakal J; Sharma S
    Retina; 2004 Feb; 24(1):19-22. PubMed ID: 15076939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Timing of vitrectomy for proliferative diabetic retinopathy in cases with type II diabetes mellitus].
    Li X; Jiang Y; Ye C; Li C
    Zhonghua Yan Ke Za Zhi; 1999 Mar; 35(2):116-8. PubMed ID: 11835788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of ILM peeling in vitreous surgery for proliferative diabetic retinopathy complications.
    Michalewska Z; Bednarski M; Michalewski J; Jerzy N
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(3):238-42. PubMed ID: 23676224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior chamber intraocular lens insertion during pars plana lensectomy and vitrectomy for complications of proliferative diabetic retinopathy.
    Blankenship GW; Flynn HW; Kokame GT
    Am J Ophthalmol; 1989 Jul; 108(1):1-5. PubMed ID: 2750829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitrectomy for proliferative diabetic retinopathy with severe equatorial fibrovascular proliferation.
    Han DP; Pulido JS; Mieler WF; Johnson MW
    Am J Ophthalmol; 1995 May; 119(5):563-70. PubMed ID: 7733181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.